USFDA removes import alert imposed on Divis Laboratories’ Unit-II at Visakhapatnam

15 Nov 2017 Evaluate

The US Food and Drug Administration (USFDA) h as removed the Import Alert 66-40 on Divis Laboratories’ Unit-II at Visakhapatnam. The regulator had earlier imposed the Import Alert on the company’s Unit-II at Visakhapatnam.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×